Search

Author/Creator Omarini, C.

1. Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients. Issue 4 (April 2017)

Authors:
Omarini, C.; Guaitoli, G.; Noventa, S.; Andreotti, A.; Gambini, A.; Palma, E.; Papi, S.; Tazzioli, G.; Balduzzi, S.; Dominici, M.; Cascinu, S.; Piacentini, F.
Journal:
European journal of surgical oncology
Issue:
Volume 43:Issue 4(2017:Apr.)
Page Start:
613
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P120 Cardiac safety of pertuzumab, trastuzumab and standard chemotherapy as neoadjuvant treatment for HER2 positive breast cancer: real world data from NeoPowER trial. (April 2023)

Authors:
Canino, F.; Barbolini, M.; De Giorgi, U.; Dominici, M.; Gianni, L.; Moscetti, L.; Omarini, C.; Zamagni, C.; Molinaro, A.; Antonelli, G.; Baglio, F.; Martinelli, G.; Natalizio, S.; Ponzoni, O.; Piacentini, F.
Journal:
Breast
Issue:
Volume 68(2023)Supplement
Page Start:
S60
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer. (October 2022)

Authors:
Viansone, A.; Pellegrino, B.; Omarini, C.; Pistelli, M.; Boggiani, D.; Sikokis, A.; Uliana, V.; Zanoni, D.; Tommasi, C.; Bortesi, B.; Bonatti, F.; Piacentini, F.; Cortesi, L.; Camisa, R.; Sgargi, P.; Michiara, M.; Musolino, A.
Journal:
Breast
Issue:
Volume 65(2022)
Page Start:
145
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗